Artelo Biosciences Inc — Cash Flow (NASDAQ:ARTL)

Financials

Cash from operating activities 4.35 M6.14 M8.01 M8.21 M8.35 M8.52 M 8.52 M Cash from investing activities 1.5 M3.44 M2.96 M3.51 M7.77 M62 K 62 K Cash from financing activities 1.98 M14.11 M0567 K112 K6.87 M 6.87 M Free cash flow 4.35 M6.14 M8.01 M8.21 M8.35 M8.52 M 8.52 M

新闻

Artelo Biosciences实施1比3反向拆股

Artelo Biosciences implements 3-for-1 reverse stock split

Artelo Biosciences报告2025年亏损1290万美元

Artelo Biosciences reports $12.9M loss for 2025

Artelo Biosciences因缺乏法定人数休会年度股东大会

Artelo Biosciences adjourns annual meeting due to lack of quorum

White House launches Medicare pilot program for CBD reimbursement

Artelo的FABP5抑制剂在焦虑和抑郁治疗方面显示出前景

Artelo’s FABP5 inhibitor shows promise for anxiety and depression

Artelo Biosciences任命Mark Spring为新任首席财务官

Artelo Biosciences appoints Mark Spring as new CFO

Artelo Biosciences任命Mark Spring为首席财务官并修订高管协议